-
Something wrong with this record ?
Quality of life of patients with structural heart disease undergoing concomitant CryoMaze procedures for persistent atrial fibrillation - randomised comparison of a hybrid approach and CryoMaze alone
Iva Šafaříková, Alan Bulava, Pavel Osmančík, Dan Wichterle, Aleš Mokráček, Petr Budera, Petr Kačer, Linda Vetešková, Petr Němec, Tomáš Skála, Petr Šantavý, Jan Chovančík, Piotr Branny, Vitalii Rizov, Miroslav Kolesár, Marian Rybář
Language English Country Czech Republic
Document type Research Support, Non-U.S. Gov't, Comparative Study
NLK
Directory of Open Access Journals
from 2014
ProQuest Central
from 2005-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2005
- Keywords
- CryoMaze,
- MeSH
- Atrial Fibrillation * surgery MeSH
- Cardiac Surgical Procedures methods MeSH
- Catheter Ablation methods adverse effects MeSH
- Coronary Artery Bypass methods MeSH
- Quality of Life MeSH
- Middle Aged MeSH
- Humans MeSH
- Maze Procedure * methods MeSH
- Surveys and Questionnaires MeSH
- Aged MeSH
- Statistics as Topic MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
Aims: We aimed to compare patients' quality of life (QoL) after two types of atrial fibrillation (AF) treatment: a hybrid ablation strategy and a surgical CryoMaze procedure alone. Methods and results: Patients with non-paroxysmal AF undergoing coronary artery bypass grafting and/or valve repair/replacement with concomitant CryoMaze procedure were randomly assigned to undergo either radiofrequency catheter ablation after three months (Hybrid Group) or no further treatment (Surgery Group). QoL was compared using the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire. The AFEQT score was converted to the scale of 0 to 100 per cent points, i.e., a score of 0 corresponds to complete disability (or responding "extremely" limited, difficult, or bothersome to all questions answered), and a score of 100 corresponds to no disability (or responding "not at all" limited, difficult, or bothersome to all questions answered). In 106 Hybrid Group patients and 109 Surgery Group patients, both baseline and 12-month AFEQT data were available for final analysis. Patients' QoL did not differ between the Hybrid and Surgery Groups at baseline. At 12 months post-procedure, QoL improved significantly in both groups (from 61.9 ± 16.3 to 86.5 ± 13.4 and from 58.6 ± 14.9 to 81.5 ± 16.7 in the Hybrid Group and Surgery Group, respectively, P < 0.001). The 12-month AFEQT score was significantly higher in the Hybrid Group compared to the Surgery Group (P = 0.017). In an analysis based on AF recurrence, the QoL at 12 months was significantly higher in patients without AF recurrences compared to patients with AF recurrences (86.2 ± 14.0 vs 80.2 ± 16.8, P = 0.005). Conclusion: Compared to the CryoMaze procedure alone, the hybrid ablation strategy was associated with higher QoL 12 months post-procedure in patients with non-paroxysmal AF undergoing cardiac surgery for structural heart disease. Arrhythmia recurrence was the most significant denominator of the QoL after concomitant AF surgery.
Centre of Cardiovascular Surgery and Transplantation Brno
České Budějovice Hospital Cardiac Centre České Budějovice
Charles University and University Hospital Královské Vinohrady 3rd Faculty of Medicine Prague
Czech Technical University Prague Faculty of Biomedical Engineering Kladno
Hospital Agel Třinec Podlesí Třinec
Institute for Clinical and Experimental Medicine Prague
Masaryk Hospital Ústí nad Labem
Palacký University and University Hospital Olomouc Faculty of Medicine and Dentistry Olomouc
University of South Bohemia in České Budějovice Faculty of Health and Social Sciences
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24005342
- 003
- CZ-PrNML
- 005
- 20240524222449.0
- 007
- ta
- 008
- 240404s2024 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.32725/kont.2024.012 $2 doi
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šafaříková, Iva $u University of South Bohemia in České Budějovice, Faculty of Health and Social Sciences; České Budějovice Hospital, Cardiac Centre, České Budějovice $7 xx0229301
- 245 10
- $a Quality of life of patients with structural heart disease undergoing concomitant CryoMaze procedures for persistent atrial fibrillation - randomised comparison of a hybrid approach and CryoMaze alone / $c Iva Šafaříková, Alan Bulava, Pavel Osmančík, Dan Wichterle, Aleš Mokráček, Petr Budera, Petr Kačer, Linda Vetešková, Petr Němec, Tomáš Skála, Petr Šantavý, Jan Chovančík, Piotr Branny, Vitalii Rizov, Miroslav Kolesár, Marian Rybář
- 520 9_
- $a Aims: We aimed to compare patients' quality of life (QoL) after two types of atrial fibrillation (AF) treatment: a hybrid ablation strategy and a surgical CryoMaze procedure alone. Methods and results: Patients with non-paroxysmal AF undergoing coronary artery bypass grafting and/or valve repair/replacement with concomitant CryoMaze procedure were randomly assigned to undergo either radiofrequency catheter ablation after three months (Hybrid Group) or no further treatment (Surgery Group). QoL was compared using the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire. The AFEQT score was converted to the scale of 0 to 100 per cent points, i.e., a score of 0 corresponds to complete disability (or responding "extremely" limited, difficult, or bothersome to all questions answered), and a score of 100 corresponds to no disability (or responding "not at all" limited, difficult, or bothersome to all questions answered). In 106 Hybrid Group patients and 109 Surgery Group patients, both baseline and 12-month AFEQT data were available for final analysis. Patients' QoL did not differ between the Hybrid and Surgery Groups at baseline. At 12 months post-procedure, QoL improved significantly in both groups (from 61.9 ± 16.3 to 86.5 ± 13.4 and from 58.6 ± 14.9 to 81.5 ± 16.7 in the Hybrid Group and Surgery Group, respectively, P < 0.001). The 12-month AFEQT score was significantly higher in the Hybrid Group compared to the Surgery Group (P = 0.017). In an analysis based on AF recurrence, the QoL at 12 months was significantly higher in patients without AF recurrences compared to patients with AF recurrences (86.2 ± 14.0 vs 80.2 ± 16.8, P = 0.005). Conclusion: Compared to the CryoMaze procedure alone, the hybrid ablation strategy was associated with higher QoL 12 months post-procedure in patients with non-paroxysmal AF undergoing cardiac surgery for structural heart disease. Arrhythmia recurrence was the most significant denominator of the QoL after concomitant AF surgery.
- 650 _7
- $a senioři $7 D000368 $2 czmesh
- 650 _7
- $a ženské pohlaví $7 D005260 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 650 _7
- $a mužské pohlaví $7 D008297 $2 czmesh
- 650 _7
- $a lidé středního věku $7 D008875 $2 czmesh
- 650 _7
- $a kvalita života $7 D011788 $2 czmesh
- 650 _7
- $a kardiochirurgické výkony $x metody $7 D006348 $2 czmesh
- 650 17
- $a fibrilace síní $x chirurgie $7 D001281 $2 czmesh
- 650 _7
- $a koronární bypass $x metody $7 D001026 $2 czmesh
- 650 _7
- $a průzkumy a dotazníky $7 D011795 $2 czmesh
- 650 _7
- $a katetrizační ablace $x metody $x škodlivé účinky $7 D017115 $2 czmesh
- 650 17
- $a maze procedura $x metody $7 D000079042 $2 czmesh
- 650 _7
- $a statistika jako téma $7 D013223 $2 czmesh
- 653 00
- $a CryoMaze
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 655 _7
- $a srovnávací studie $7 D003160 $2 czmesh
- 700 1_
- $a Bulava, Alan, $u University of South Bohemia in České Budějovice, Faculty of Health and Social Sciences; České Budějovice Hospital, Cardiac Centre, České Budějovice $d 1974- $7 xx0106839
- 700 1_
- $a Osmančík, Pavel, $u Charles University and University Hospital Královské Vinohrady, 3rd Faculty of Medicine, Prague $d 1972- $7 xx0104796
- 700 1_
- $a Wichterle, Dan $u Institute for Clinical and Experimental Medicine, Prague $7 xx0101417
- 700 1_
- $a Mokráček, Aleš, $u University of South Bohemia in České Budějovice, Faculty of Health and Social Sciences; České Budějovice Hospital, Cardiac Centre, České Budějovice $d 1966- $7 xx0094268
- 700 1_
- $a Budera, Petr $u Institute for Clinical and Experimental Medicine, Prague $7 xx0270813
- 700 1_
- $a Kačer, Petr, $u Charles University and University Hospital Královské Vinohrady, 3rd Faculty of Medicine, Prague $d 1969 září 21.- $7 xx0230547
- 700 1_
- $a Vetešková, Linda $u Centre of Cardiovascular Surgery and Transplantation, Brno $7 xx0229433
- 700 1_
- $a Němec, Petr, $u Centre of Cardiovascular Surgery and Transplantation, Brno $d 1954- $7 xx0033694
- 700 1_
- $a Skála, Tomáš $u Palacký University and University Hospital Olomouc, Faculty of Medicine and Dentistry, Olomouc $7 xx0137536
- 700 1_
- $a Šantavý, Petr, $u Palacký University and University Hospital Olomouc, Faculty of Medicine and Dentistry, Olomouc $d 1973- $7 xx0211055
- 700 1_
- $a Chovančík, Jan $u Hospital Agel Třinec-Podlesí, Třinec $7 xx0070638
- 700 1_
- $a Branny, Piotr, $u Hospital Agel Třinec-Podlesí, Třinec $d 1968- $7 xx0051478
- 700 1_
- $a Rizov, Vitalii $u Masaryk Hospital, Ústí nad Labem $7 xx0304648
- 700 1_
- $a Kolesár, Miroslav $u Masaryk Hospital, Ústí nad Labem $7 xx0148604
- 700 1_
- $a Rybář, Marian $u Czech Technical University in Prague, Faculty of Biomedical Engineering, Kladno $7 xx0311830
- 773 0_
- $t Kontakt $x 1212-4117 $g Roč. 26, č. 1 (2024), s. 9-16 $w MED00011467
- 856 41
- $u https://kont.zsf.jcu.cz/artkey/knt-202401-0003_quality-of-life-of-patients-with-structural-heart-disease-undergoing-concomitant-cryomaze-procedures-for-persis.php $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2178 $c 1249 $y p $z 0
- 990 __
- $a 20240404 $b ABA008
- 991 __
- $a 20240524222442 $b ABA008
- 999 __
- $a ok $b bmc $g 2085793 $s 1215102
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2024 $b 26 $c 1 $d 9-16 $e 20240315 $i 1212-4117 $m Kontakt $x MED00011467
- LZP __
- $c NLK189 $d 20240522 $b NLK111 $a Actavia-MED00011467-20240404